Blog

Angelo Dipasquale: How to manage chemotherapy in a liver transplant recipient diagnosed with an IDH mutant glioma?

Angelo Dipasquale/LinkedIn

Mar 25, 2025, 08:26

Angelo Dipasquale: How to manage chemotherapy in a liver transplant recipient diagnosed with an IDH mutant glioma?

Angelo Dipasquale, Medical Neurooncologist at Humanitas Research Hospital, posted on LinkedIn, about recent paper he and colleagues co-authored:

“How to properly manage chemotherapy in a liver transplant recipient diagnosed with an IDH mutant glioma?

At that time, we did not find evidence to drive our decision making.
Now, we are happy to share the first case study exploring this rare scenario of such a rare tumour.”

“Case study: successful full-course chemotherapy administration in a liver transplant recipient diagnosed with CNS WHO Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.”

Authors: Angelo Dipasquale, Agnese Losurdo, Pasquale Persico, Silvia Aimola, Bethania Fernandes, Laura Evangelista, Matteo Simonelli

Angelo Dipasquale

Agnese Losurdo Angelo Dipasquale Bethania Fernandes cancer chemotherapy EANO IDH-mutant glioma Laura Evangelista liver transplant Matteo Simonelli OncoDaily Oncology Pasquale Persico Silvia Aimola

Does Artificial Sweeteners Cause Cancer? Myths and Facts

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram